Investment Q&A

Q: Earlier in December the company raised $17 million of new convertible debt in a private placement at a 12 per-cent interest rate. At what price per share is this debt convertible? Other observations on this Co.
Del

Q: Can you give me your opinion on swp at this price

Q: Hi Peter and team:
Just a note to say thank you. Two points: First, I sent in a question which I thought was almost an unfair one and virtually impossible. You actually answered it and provided your methodology with exactly what I needed. Second, I submitted my question late Friday, thinking I wouldn't receive an answer until Monday or so. I open up my email Saturday morning to find a reply time stamped at 2:00 am. Wow...needless to say, you made my day.
Thanks for the great service...above and beyond!
Please take Christmas Day off...Steve

Q: May I have your opinion on this stock? I looks like it has some potential. Merry Christmas

Q: In a reply to a question from Vinod on Dec. 14th, you referred to a "DOG investigation".
What kind of an animal is this ?

Jacques IDS

Q: Both of these has been hitting all time highs.
Looks like STNE passed the 20B market cap and kept going. Any thoughts on valuation?
Re Okta looking to add to round out the position. Worth waiting for it to settle down or things looks good into 2021 and beyond so good as any time to hit the buy button. Maybe the recent cyber attack is helping here.

Thanks

Q: Would you hold both of these companies, or are they too similar?

Thanks!

Q: Will Telus be a major player in the 5G roll out? What companies do you suggest?

Q: Good morning 5i, question for you on prospects for Portage Biotech for growth, a friend of mine who was an earlier investor in this company, really likes the space and specifically the Chairman and Director Greg Bailey as he said he has a great track record with previous companies.

This is from Portage's site (CEO of Juvanescence. Managing Partner of Palantir Group, Inc, co-founder of Ascent Healthcare Solutions, VirnetX Inc. (Biohaven (BHVN:NYSE), and DuraMedic Inc. He was the initial financier and an independent Director of Medivation, Inc. (MDVN:NASDAQ), from 2005 to 2012. He also served as the Managing Director and co-Head of Life Sciences at MDB Capital Group LLC from May 2004 to December 2006.)

Do you know of Greg and would you feel comfortable with his history? I am guessing you do not know much about the company and in the biotech/cancer space there is tons of risk so that is fully understood, but looking to add to that sector for long term growth 15 plus years out.

Q: Good morning 5i.
Yesterday I asked a question about options and you replied that one of your favourite strategies is to sell a call and a put on the same stock. I suppose I could run a few examples to try to see how this works. But, perhaps the best is to ask you to expand on that strategy a bit. Any particular things you look at in this strategy?

Q: My 18-year-old daughter is interested in the stock market and wants to understand the value of owning stocks. She is looking to follow 6 stocks. She has some post-secondary aspirations for next year and would like your suggestions on 3 stable and 3 growth-oriented companies that you would buy today. Thanks

Q: A little while ago, Stephen asked a question about some Reits and BSR was mentioned. In your answer, you suggest it was not cheap, based on 22x cash flow. A couple of questions: would other matrices also show it to be not cheap? About P/E, it shows at 5 on my Portfolio Tracking, but on the web page from my booker, it says 12.49....why the difference? Last, while I do like the business focus of BSR, CAP Reit is often mentioned favourably for this sector; can you briefly compare these 2 and suggest which you would prefer, and why? Thank you for your excellent service.

Q: What are your thoughts on their quarter, Is the sell of warranted?

Q: I have seen many articles in which advisors recommend all-in-one portfolios as core holdings. I understand the value of these portfolios given the rebalancing effect, when there is a mix of bonds and equities (e.g. VBAL, XBAL). However, I do not understand the benefit of the all-equity, all-in-one portfolio (e.g. VEQT, XEQT) compared to an all-world equity ETF (e.g. XAW, XWD). The all-equity, all-in-one portfolios are overweight Canada vis-a-vis global market capitalizations. It seems to me that the all-equity, all-in-one portfolios are "betting" that Canadian equities will outperform the rest of the world. Yet, most articles I read suggest the opposite, and recommend that Canadians invest increasingly internationally (in fact, I can not recall in the last few years any article suggesting Canadian outperformance).

It seems to me that the all world ETFs (XAW, XWD) are a better bet, but I am concerned that I am missing something given the popularity of the all-equity, all-in-one portfolios. What do you see as the advantage of the all equity, all-in-one portfolios over the all world all-equity ETFs? Why do major firms such as Vanguard and Blackrock have a Canadian overweight in their all-equity, all-in-one portfolios? For a long-term core equity-only holding, do you recommend the all-in-one portfolio (e.g. VEQT, XEQT) over the global equity ETFs (XAW, XWD)? Is there any other ETF you would recommend instead?

Many thanks for your excellent advice.

Q: Happy holidays to all at 5i. In this most difficult of years, it was great that you were all at our financial backs and gave us one less thing to stress about.

I purchased GOOS about a month ago on your recommendation. Since then you seem to be touting DOO more strongly. I don't normally chase stocks but I was wondering in this case if you feel a much stronger case can be made for DOO over GOOS? I only ask in this situation because I have always been leery of discretionary stocks - particularly those that are fashion related - because tastes can change very quickly, I am a buy and hold investor so I am not looking for a just quick flip.

Appreciate your insight.

Paul F.

Q: With the news of a higher bid. Would you sell your shares into the market or just wait till the end.

And why?

Thanks

Sheldon

Q: Is there any Active or Non-Active ETF you would recommend in CDN dollars with a similar performance like ARKG?

Thanks for the great service

Q: Novo is down significantly since Kirkland sold, is it worth buying more or do you think it is going to be depressed for some time? What are the insider positions on this now?

Q: With resources starting to recover is it worth hanging onto PEA? What are your thoughts on this company.

Q: In order to increase my US holdings I am planning to exchange Cdn $ to US. It appears as the Cdn is creeping towards 80 cents US. What is driving the Cdn dollar? Does not appear as oil or finance is or for that matter the Cdn economy. Should I wait for the trend to reverse?